Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company’s employees, the National Healthcare Security Administration (NHSA) said on Saturday.
Read More
Chinese authorities summon AstraZeneca China on suspected insurance fraud